Fresenius Medical Care AG & Co. KGaA Cash Flow Conversion Efficiency
Fresenius Medical Care AG & Co. KGaA cash flow conversion efficiency. Based on the latest financial reports, Fresenius Medical Care AG & Co. KGaA (FME) has a cash flow conversion efficiency ratio of 0.064x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€860.30 Million ≈ $1.01 Billion USD) by net assets (€13.53 Billion ≈ $15.82 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Fresenius Medical Care AG & Co. KGaA (1998–2025)
Cash flow conversion efficiency of Fresenius Medical Care AG & Co. KGaA from 1998 to 2025. This chart illustrates how Fresenius Medical Care AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Fresenius Medical Care AG & Co. KGaA stock quote for real-time trading data and today's change.
Fresenius Medical Care AG & Co. KGaA Cash Flow Conversion Ratio Explained
Fresenius Medical Care AG & Co. KGaA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Fresenius Medical Care AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fresenius Medical Care AG & Co. KGaA ranked by their cash flow conversion efficiency. Also see Fresenius Medical Care AG & Co. KGaA stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sprott Physical Silver
TO:PSLV
|
0.006x |
|
Chocoladefabriken Lindt & Spruengli AG Part
SW:LISP
|
-0.032x |
|
Zhejiang Zheneng Electric Power Co Ltd
SHG:600023
|
0.073x |
|
Anglo American Platinum Ltd
JSE:AMS
|
0.160x |
|
Bluescope Steel Ltd
AU:BSL
|
0.086x |
|
SHIZUOKA FIN. GROUP INC.
F:P2U
|
N/A |
|
Symrise AG
F:SY1
|
0.019x |
|
Western Mining Co Ltd
SHG:601168
|
0.053x |
Annual Cash Flow Conversion Efficiency for Fresenius Medical Care AG & Co. KGaA (1998–2025)
The table below shows the annual cash flow conversion efficiency of Fresenius Medical Care AG & Co. KGaA from 1998 to 2025. Review how much free cash does Fresenius Medical Care AG & Co. KGaA generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €14.28 Billion ≈ $16.70 Billion |
€2.68 Billion ≈ $3.13 Billion |
0.188x | +24.04% |
| 2024-12-31 | €15.77 Billion ≈ $18.44 Billion |
€2.39 Billion ≈ $2.79 Billion |
0.151x | -14.65% |
| 2023-12-31 | €14.83 Billion ≈ $17.33 Billion |
€2.63 Billion ≈ $3.07 Billion |
0.177x | +26.40% |
| 2022-12-31 | €15.45 Billion ≈ $18.06 Billion |
€2.17 Billion ≈ $2.53 Billion |
0.140x | -21.22% |
| 2021-12-31 | €13.98 Billion ≈ $16.34 Billion |
€2.49 Billion ≈ $2.91 Billion |
0.178x | -48.13% |
| 2020-12-31 | €12.33 Billion ≈ $14.42 Billion |
€4.23 Billion ≈ $4.95 Billion |
0.343x | +76.88% |
| 2019-12-31 | €13.23 Billion ≈ $15.46 Billion |
€2.57 Billion ≈ $3.00 Billion |
0.194x | +21.43% |
| 2018-12-31 | €12.90 Billion ≈ $15.08 Billion |
€2.06 Billion ≈ $2.41 Billion |
0.160x | -21.05% |
| 2017-12-31 | €10.83 Billion ≈ $12.66 Billion |
€2.19 Billion ≈ $2.56 Billion |
0.202x | +8.38% |
| 2016-12-31 | €10.89 Billion ≈ $12.74 Billion |
€2.03 Billion ≈ $2.38 Billion |
0.187x | +0.03% |
| 2015-12-31 | €9.60 Billion ≈ $11.22 Billion |
€1.79 Billion ≈ $2.10 Billion |
0.187x | +0.62% |
| 2014-12-31 | €8.25 Billion ≈ $9.64 Billion |
€1.53 Billion ≈ $1.79 Billion |
0.186x | -13.49% |
| 2013-12-31 | €6.87 Billion ≈ $8.03 Billion |
€1.47 Billion ≈ $1.72 Billion |
0.215x | -3.13% |
| 2012-12-31 | €6.96 Billion ≈ $8.14 Billion |
€1.54 Billion ≈ $1.80 Billion |
0.221x | +23.46% |
| 2011-12-31 | €6.22 Billion ≈ $7.27 Billion |
€1.12 Billion ≈ $1.30 Billion |
0.179x | -1.35% |
| 2010-12-31 | €5.66 Billion ≈ $6.61 Billion |
€1.03 Billion ≈ $1.20 Billion |
0.182x | -4.53% |
| 2009-12-31 | €4.91 Billion ≈ $5.74 Billion |
€934.57 Million ≈ $1.09 Billion |
0.190x | +11.73% |
| 2008-12-31 | €4.28 Billion ≈ $5.01 Billion |
€730.12 Million ≈ $853.59 Million |
0.170x | -19.27% |
| 2007-12-31 | €3.90 Billion ≈ $4.56 Billion |
€822.75 Million ≈ $961.88 Million |
0.211x | +15.02% |
| 2006-12-31 | €3.75 Billion ≈ $4.38 Billion |
€687.85 Million ≈ $804.17 Million |
0.184x | +9.22% |
| 2005-12-31 | €3.37 Billion ≈ $3.94 Billion |
€565.94 Million ≈ $661.65 Million |
0.168x | -25.84% |
| 2004-12-31 | €2.69 Billion ≈ $3.15 Billion |
€610.68 Million ≈ $713.95 Million |
0.227x | -2.08% |
| 2003-12-31 | €2.59 Billion ≈ $3.02 Billion |
€598.71 Million ≈ $699.96 Million |
0.231x | +19.10% |
| 2002-12-31 | €2.70 Billion ≈ $3.15 Billion |
€524.06 Million ≈ $612.68 Million |
0.194x | +20.79% |
| 2001-12-31 | €2.96 Billion ≈ $3.46 Billion |
€476.82 Million ≈ $557.45 Million |
0.161x | +11.02% |
| 2000-12-31 | €2.87 Billion ≈ $3.36 Billion |
€416.60 Million ≈ $487.05 Million |
0.145x | -16.43% |
| 1999-12-31 | €2.01 Billion ≈ $2.35 Billion |
€348.80 Million ≈ $407.78 Million |
0.173x | +53.79% |
| 1998-12-31 | €2.03 Billion ≈ $2.37 Billion |
€228.51 Million ≈ $267.16 Million |
0.113x | -- |
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more